2.9(top 20%)
impact factor
4.4K(top 5%)
papers
56.7K(top 5%)
citations
99(top 5%)
h-index
3.1(top 20%)
impact factor
4.7K
all documents
60.6K
doc citations
134(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retrovirusesRetrovirology2011340
2SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4+T-cellsRetrovirology2012302
3HIV-1 Vif, APOBEC, and Intrinsic ImmunityRetrovirology2008290
4The discovery of endogenous retrovirusesRetrovirology2006287
5Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in humanRetrovirology2007287
6HIV-1 transcription and latency: an updateRetrovirology2013271
7Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replicationRetrovirology2008251
8HIV-1 nef suppression by virally encoded microRNARetrovirology2004231
9The HTLV-1 Tax interactomeRetrovirology2008225
10Macrophages and their relevance in Human Immunodeficiency Virus Type I infectionRetrovirology2012213
11TRIM5alpha selectively binds a restriction-sensitive retroviral capsidRetrovirology2005212
12Classification and characterization of human endogenous retroviruses; mosaic forms are commonRetrovirology2016211
13Host-virus interaction: a new role for microRNAsRetrovirology2006209
14Discovery of adult T-cell leukemiaRetrovirology2005191
15MicroRNA profile changes in human immunodeficiency virus type 1 (HIV-1) seropositive individualsRetrovirology2008189
16The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNARetrovirology2015189
17The control of viral infection by tripartite motif proteins and cyclophilin ARetrovirology2007188
18HERV-H RNA is abundant in human embryonic stem cells and a precise marker for pluripotencyRetrovirology2012188
19HIV interactions with monocytes and dendritic cells: viral latency and reservoirsRetrovirology2009184
20Relative resistance of HIV-1 founder viruses to control by interferon-alphaRetrovirology2013183
21Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategiesRetrovirology2009182
22HIV-1 encoded candidate micro-RNAs and their cellular targetsRetrovirology2004181
23Discovery of a new human T-cell lymphotropic virus (HTLV-3) in Central AfricaRetrovirology2005181
24Factor correction as a tool to eliminate between-session variation in replicate experiments: application to molecular biology and retrovirologyRetrovirology2006181
25Rapid inflammasome activation in microglia contributes to brain disease in HIV/AIDSRetrovirology2014180
26SIVSM/HIV-2 Vpx proteins promote retroviral escape from a proteasome-dependent restriction pathway present in human dendritic cellsRetrovirology2007177
27Integrase and integration: biochemical activities of HIV-1 integraseRetrovirology2008177
28HIV-1 associated dementia: symptoms and causesRetrovirology2006176
29SAMHD1 restricts HIV-1 infection in dendritic cells (DCs) by dNTP depletion, but its expression in DCs and primary CD4+T-lymphocytes cannot be upregulated by interferonsRetrovirology2012166
30Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndromeRetrovirology2010164
31Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanismsRetrovirology2005163
32HIV-1 Nef: at the crossroadsRetrovirology2008160
33The discovery of the first human retrovirus: HTLV-1 and HTLV-2Retrovirology2005159
34Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineageRetrovirology2010159
35Changes in microRNA expression profiles in HIV-1-transfected human cellsRetrovirology2005157
36The macrophage in HIV-1 infection: From activation to deactivation?Retrovirology2010157
37Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicityRetrovirology2015156
38HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartmentRetrovirology2010154
39HTLV-I antisense transcripts initiating in the 3'LTR are alternatively spliced and polyadenylatedRetrovirology2006153
40Retroviral superinfection resistanceRetrovirology2005150
41In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP)Retrovirology2009150
42Identification of endogenous retroviral reading frames in the human genomeRetrovirology2004148
43HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse modelRetrovirology2006148
44Common principles and intermediates of viral protein-mediated fusion: the HIV-1 paradigmRetrovirology2008146
45Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patientsRetrovirology2009143
46The Spanish HIV BioBank: a model of cooperative HIV researchRetrovirology2009142
47Disease-associated XMRV sequences are consistent with laboratory contaminationRetrovirology2010141
48HIV drug resistance against strand transfer integrase inhibitorsRetrovirology2017141
49HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expressionRetrovirology2009140
50Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patientsRetrovirology2012140